SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GRANULES INDIA

BSE: 532482 29 Jun 2025
Healthcare
₹ 497.45
Granules India Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GRANULES INDIA - Share Price & Details

Market Cap
₹12,064
High /Low
725.0 / 412.0
Stock P/E
25.2
Book Value
₹153.0
Dividend Yield
0.3
ROCE
15.1
ROE
₹13.8
Face Value
1.0
PEG Ratio
2.89
EVEBITDA
₹13.5
Debt
1,455
CMP / FCF
52.8
Debt to equity
₹0.39
NP Ann
502
High price all time
725.0
Piotroski score
₹7.0
Graham Number
267.0
No. Eq. Shares
24.3
Net CF
₹82.8
Net profit
502
Price to book value
3.25
Interest Coverage
₹7.1
Low price all time
2.53
Industry PE
32.7
Reserves
₹3,691
Free Cash Flow
₹297

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
GRANULES INDIA LTD.NANANANA12,06425.2
MARKSANS PHARMA LTD.3071.74375.912993.570.831087628.6
PROCTER & GAMBLE HEALTH LIMITENANANANA980537.7

Peer Comparison Chart


About GRANULES INDIA

Granules India Ltd., with Security Code 532482, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Granules India Share Price Target at Rs 612: Deven Choksey Research

(09 Jun 2025)
Deven Choksey Research has issued a BUY recommendation for Granules India Limited, setting a 12-month target of Rs 612 from the current...
Read more →

Granules India Share Price Today - Granules India Stock Price Live NSE/BSE

(29 May 2025)
Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Telangana, India.
Read more →

Q4 Results Today: MTNL Net Loss Narrows; IRCTC Profit Beats Estimates, Welspun Corp Profit More Than Doubles

(29 May 2025)
As many as 400 companies posted their results for the quarter ended March, with heavyweights like Steel Authority of India, Indian Railway...
Read more →

Granules India posts Q4 FY25 PAT at Rs. 152 Cr

(29 May 2025)
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility.
Read more →

Granules India Plans To Resume Normal Operations At Gagillapur Facility By Q3

(29 May 2025)
Granules India faced a setback after the FDA issued a warning to the company in February 2025 over some compliance concerns at the...
Read more →

Granules India Limited (NSE:GRANULES) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

(29 May 2025)
Investors in Granules India Limited ( NSE:GRANULES ) had a good week, as its shares rose 2.4% to close at ₹531...
Read more →